Dextran derivatives endowed, particularly with anti-coagulant pr

Details Dextran derivatives endowed, particularly with anti-coagulant pr Dextran derivatives endowed, particularly with anti-coagulant pr

1984-11-30

1988-04-26

Griffin, Ronald W.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

536 53, 536112, 514832, 514833, A61K 3170, A61K 31725, C08B 3702

Patent

active

047405945

ABSTRACT:
The dextran derivatives have a molecular weight higher than about 5000 daltons and comprise statistically at least about 35% of units substituted by radicals having a COO.sup.- function and at least 3% of units comprising a group of structure ##STR1## wherein R.sub.1 is a single bond; or a ##STR2## group, R.sub.2 is an anion of an inorganic or an organic salt and n is a number from 1 to 4.

REFERENCES:
patent: 2216617 (1940-10-01), Katz
patent: 2989518 (1961-06-01), Novak
patent: 4411891 (1983-10-01), Mizutani et al.
patent: 4591638 (1986-05-01), Ahrgren et al.

Affiliated with

Also associated with

Rating

Dextran derivatives endowed, particularly with anti-coagulant pr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dextran derivatives endowed, particularly with anti-coagulant pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dextran derivatives endowed, particularly with anti-coagulant pr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-820495